Efficacy of cabazitaxel, abiraterone, enzalutamide and docetaxel sequence in men with metastatic castration-resistant prostate cancer (mCRPC) in real life practice: The multinational, retrospective, observational CATS study
Latest Information Update: 08 Mar 2019
At a glance
- Drugs Abiraterone acetate (Primary) ; Cabazitaxel (Primary) ; Docetaxel (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms CATS registry
- 16 Feb 2019 Results presented at the 2019 Genitourinary Cancers Symposium